Outlook: The Biotech buck doesn't stop here

IT IS HARD, reading yesterday's "we did no wrong" circular from British Biotech, to accept that this finally puts the lid on the extraordinary sequence of allegations which have coloured the company's affairs for the last few months. A brave attempt is made to rebut, point by point, the demolition job performed on the company by its former head of research, Dr Andrew Millar, and to some extent it succeeds. Crucially, however, the circular fails to give investors much confidence in the products the company has been developing, nor does it explain adequately why the company allowed, indeed encouraged, expectations of these compounds to become so inflated.

Furthermore, British Bio admits ominously that the London stock exchange has reopened its investigation into share dealings by directors, and worse, that the the US Securities and Exchange Commission has begun a top level investigation into whether investors were misled. This could lay the company open to corporate prosecution and be the grounding for an overwhelming array of class actions against the company and its advisers. Now why does it seem so unlikely that Dr Keith McCullagh's agreement to stand down as chief executive marks the final denouement?

And if Dr McCullagh has behaved honourably and impeccably throughout, as the circular insists, who then should shareholders blame for this terrible debacle, this sickening loss in shareholder value. The company would like us to believe it's all down to Dr Millar, who it paints as an embittered, misguided man with a very large axe to grind. Whatever the truth, the finger might also reasonably be pointed at the non-executive directors, and particularly the company's chairman, John Raisman, a former head of Shell UK. Dr Millar began to raise his concerns internally at British Bio long before he went public with them. It must have been obvious that a serious difference of opinion was emerging over the company's prospects and development.

Why was it that the chairman and other non-execs failed to nip this dispute in the bud or get to the bottom of its causes? Most biotechs are run by faintly autocratic, visionary biochemists who believe in the potential of their discoveries with all the passion of a zealot. They are not businessmen or even entrepreneurs out of the usual mould. It is incumbent on the non-execs to be especially careful to rein in the over- enthusiasm of their executives in cases like these. Plainly in this case, they failed utterly to do so. The buck shouldn't stop with Dr McCullagh. Mr Raisman's continued presence at the company inspires little confidence in the future.

PROMOTED VIDEO
News
ebooksAn evocation of the conflict through the eyes of those who lived through it
Life and Style
techApp to start sending headlines, TV clips and ads to your phone
Arts and Entertainment
Taylor Swift crawls through the legs of twerking dancers in her 'Shake It Off' music video
musicEarl Sweatshirt thinks so
Life and Style
tech
Arts and Entertainment
Daniel Radcliffe and Zoe Kazan in What If
filmReview: Actor swaps Harry Potter for Cary Grant in What If
News
Our resilience to stress is to a large extent determined by our genes
science
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Asset Finance Solicitor

Highly Competitive Salary: Austen Lloyd: CITY - ASSET FINANCE - An outstanding...

HR Analyst - Banking - Bristol - £350-£400

£350 - £400 per day: Orgtel: HR Analyst - Banking - Bristol - £350 - £400 per ...

Techincal Accountant-Insurance-Bank-£550/day

£475 - £550 per day + competitive: Orgtel: Senior Technical Accountant-Insuran...

Sales Performance Manager, Gloucester - £290 p/day

£200 - £290 per annum + competitive: Orgtel: Sales Performance Manager, Key Ba...

Day In a Page

Ferguson: In the heartlands of America, a descent into madness

A descent into madness in America's heartlands

David Usborne arrived in Ferguson, Missouri to be greeted by a scene more redolent of Gaza and Afghanistan
BBC’s filming of raid at Sir Cliff’s home ‘may be result of corruption’

BBC faces corruption allegation over its Sir Cliff police raid coverage

Reporter’s relationship with police under scrutiny as DG is summoned by MPs to explain extensive live broadcast of swoop on singer’s home
Lauded therapist Harley Mille still in limbo as battle to stay in Britain drags on

Lauded therapist still in limbo as battle to stay in Britain drags on

Australian Harley Miller is as frustrated by court delays as she is with the idiosyncrasies of immigration law
Lewis Fry Richardson's weather forecasts changed the world. But could his predictions of war do the same?

Lewis Fry Richardson's weather forecasts changed the world...

But could his predictions of war do the same?
Kate Bush asks fans not to take photos at her London gigs: 'I want to have contact with the audience, not iPhones'

'I want to have contact with the audience, not iPhones'

Kate Bush asks fans not to take photos at her London gigs
Under-35s have rated gardening in their top five favourite leisure activities, but why?

Young at hort

Under-35s have rated gardening in their top five favourite leisure activities. But why are so many people are swapping sweaty clubs for leafy shrubs?
Tim Vine, winner of the Funniest Joke of the Fringe award: 'making a quip as funny as possible is an art'

Beyond a joke

Tim Vine, winner of the Funniest Joke of the Fringe award, has nigh-on 200 in his act. So how are they conceived?
The late Peter O'Toole shines in 'Katherine of Alexandria' despite illness

The late Peter O'Toole shines in 'Katherine of Alexandria' despite illness

Sadly though, the Lawrence of Arabia star is not around to lend his own critique
Wicken Fen in Cambridgeshire: The joy of camping in a wetland nature reserve and sleeping under the stars

A wild night out

Wicken Fen in Cambridgeshire offers a rare chance to camp in a wetland nature reserve
Comic Sans for Cancer exhibition: It’s the font that’s openly ridiculed for its jaunty style, but figures of fun have their fans

Comic Sans for Cancer exhibition

It’s the font that’s openly ridiculed for its jaunty style, but figures of fun have their fans
Besiktas vs Arsenal: Five things we learnt from the Champions League first-leg tie

Besiktas vs Arsenal

Five things we learnt from the Champions League first-leg tie
Rory McIlroy a smash hit on the US talk show circuit

Rory McIlroy a smash hit on the US talk show circuit

As the Northern Irishman prepares for the Barclays, he finds time to appear on TV in the States, where he’s now such a global superstar that he needs no introduction
Boy racer Max Verstappen stays relaxed over step up to Formula One

Boy racer Max Verstappen stays relaxed over step up to F1

The 16-year-old will become the sport’s youngest-ever driver when he makes his debut for Toro Rosso next season
Fear brings the enemies of Isis together at last

Fear brings the enemies of Isis together at last

But belated attempts to unite will be to no avail if the Sunni caliphate remains strong in Syria, says Patrick Cockburn
Charlie Gilmour: 'I wondered if I would end up killing myself in jail'

Charlie Gilmour: 'I wondered if I'd end up killing myself in jail'

Following last week's report on prison suicides, the former inmate asks how much progress we have made in the 50 years since the abolition of capital punishment